GlassScriptPhysician profile
Kae L Ferber
NPI 1255384749
$17,768.40
in general payments reported to CMS, 2019-2025
55 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what 91% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,780 · 2020: $1,632 · 2021: $2,579 · 2022: $3,159 · 2023: $2,579 · 2024: $2,817 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,618.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $2,801.39 | 2019-2025 | Evenity, Repatha, Prolia |
| Novo Nordisk INC | $1,560.14 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,035.11 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Janssen Pharmaceuticals, INC | $911.16 | 2019-2024 | Xarelto |
| Pfizer INC. | $716.08 | 2019-2025 | |
| Lilly USA, LLC | $628.62 | 2019-2025 | Kisunla, Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $595.81 | 2019-2025 | Gardasil 9, Pneumovax 23, Vaxneuvance |
| Astrazeneca Pharmaceuticals LP | $573.52 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Novartis Pharmaceuticals Corporation | $573.21 | 2019-2025 | |
| Boston Scientific Corporation | $551.50 | 2020-2024 | Watchman Flx |
| Esperion Therapeutics, INC. | $549.75 | 2020-2025 | Nexletol |
| Eisai INC. | $541.62 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $528.71 | 2021-2023 | |
| Radius Health, INC. | $526.23 | 2019-2025 | Tymlos |
| Glaxosmithkline, LLC. | $513.11 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $434.39 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $430.17 | 2019-2025 | Livalo, Seglentis, Zoryve |
| Medtronic, INC. | $402.59 | 2022-2025 | Nuvent, Endurant Iis, Propel |
| Horizon Therapeutics Plc | $394.42 | 2021-2023 | Krystexxa |
| Abbvie INC. | $352.26 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $317.24 | 2019-2025 | Evkeeza |
| Sumitomo Pharma America, INC. | $289.49 | 2023-2024 | Gemtesa |
| Medtronic Vascular, INC. | $227.71 | 2019-2020 | |
| Inspire Medical Systems, INC. | $220.54 | 2022-2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $220.26 | 2019-2020 | |
| Exact Sciences Corporation | $210.86 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Paratek Pharmaceuticals, INC. | $200.34 | 2022-2024 | Nuzyra |
| Abbott Laboratories | $184.85 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $160.06 | 2022-2023 | Xifaxan |
| Silk Road Medical, INC. | $133.44 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Currax Pharmaceuticals LLC | $131.61 | 2020-2022 | |
| Ibsa Pharma INC. | $98.40 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $86.87 | 2019 | |
| Astellas Pharma US INC | $82.29 | 2019-2022 | |
| Sanofi Pasteur INC. | $66.66 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $59.63 | 2021 | |
| Corium, LLC | $55.26 | 2023-2024 | Azstarys |
| Takeda Pharmaceuticals U.S.A., INC. | $50.41 | 2019-2022 | |
| Abiomed | $41.00 | 2024 | Impella |
| Biohaven Pharmaceuticals, INC. | $38.34 | 2021 | |
| Vivus LLC | $37.20 | 2019 | |
| Corcept Therapeutics | $34.72 | 2025 | Korlym |
| Amryt Pharma Holdings LTD | $19.86 | 2020 | |
| Lundbeck LLC | $19.80 | 2020 | |
| Daiichi Sankyo INC. | $19.63 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.83 | 2020 | |
| Allergan, INC. | $16.89 | 2020 | |
| Therapeuticsmd, INC. | $16.72 | 2019 | |
| Idorsia Pharmaceuticals US INC | $15.13 | 2023 | Quviviq |
| Biohaven Pharmaceutical Holding Company LTD. | $14.53 | 2022 | |
| Acella Pharmaceuticals, LLC | $14.52 | 2024 | NP Thyroid 60 |
| Almatica Pharma LLC | $12.24 | 2022 | |
| Redhill Biopharma INC. | $12.14 | 2021 | |
| Nestle Healthcare Nutrition INC. | $11.28 | 2021 | |
| Phathom Pharmaceuticals, INC. | $10.86 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kae Ferber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.